Pharmaceutical giant Novo Nordisk (NYSE: NVO) released its fourth-quarter and full-year earnings report on Feb. 5. The ...

Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...

Good day, and thank you for standing by. Welcome to the full-year 2024 Novo Nordisk earnings conference call. [Operator instructions] Please be advised that today's conference is being recorded.

Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest insulin makers of charging astronomically high prices for the diabetes ...

Denmark will increase its military budget by a combined 50 billion crowns ($6.99 billion) this year and next to address acute ...

The company’s shares rose as investors breathed a sigh of relief on strong sales growth and guidance, despite ongoing capacity constraints and fears over the U.S. demand outlook for Wegovy.

The agreement reached with Novo Nordisk covers popular brands like ... life support" Ellison was joined at Monday morning's press conference by Nicole Smith-Holt, mother of 26-year-old Alec ...

“We thus await detailed results from [Novo Nordisk’s] injectable amycretin trial at a medical conference this year to better assess the drug’s full profile,” Risinger said.

Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...

Novo Nordisk is under investor pressure for transparency regarding their obesity drug CagriSema, after trial results disappointed. Patients report weight loss but side effects like nausea. Investors ...

Novo Nordisk said these effects were more frequent ... In preclinical research presented at the Obesity Week 2024 conference in November, Corbus reported that brain levels of its drug, CRB-913 ...

Novo Nordisk has reported 22% weight loss in people ... team would take the same approach with amycretin when asked on a conference call with analysts in August. Work on the subcutaneous candidate ...